ArticleFrontiers in bioinformatics2026
BCheM: a framework integrating molecular attributes and behavioral representations for precise prediction of drug resistance across multiple disease contexts.
Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In clinical medicine, the response of diseases to drugs directly affects treatment efficacy and patient prognosis. Accurate prediction of drug responses can facilitate personalized treatment planning, enable the selection of effective medications, and reduce adverse effects. However, existing computational methods are often limited to single disease types or rely solely on molecularlevel information, making it difficult to simultaneously capture the semantic attribute features of diseases and drugs, as well as their behavioral patterns within association networks. Therefore, effectively integrating multimodal attribute information with complex relational structures for drug resistance prediction across multiple disease contexts remains a challenging problem. Methods: To address this issue, we propose a novel disease-drug resistance prediction framework, BCheM. First, a disease-drug resistance network is constructed based on experimentally validated drug response data, and rich attribute features are obtained by incorporating drug SMILES representations and disease semantic descriptions. Then, pre-trained models are employed to encode disease semantics and drug molecular structures, enabling deep representation of molecular attributes. Furthermore, a graph representation learning model that integrates Chebyshev graph convolution with a multi-head attention mechanism is developed to model and fuse behavioral features within the disease-drug network. Finally, a classifier is applied to predict potential disease-drug resistance associations. Results: Experimental results and case studies demonstrate that BCheM achieves superior performance across multiple evaluation metrics, exhibiting strong predictive capability and practical applicability. Discussion: This study provides an effective graph-based modeling approach for drug response prediction in multi-disease contexts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.